Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Antonini

Showing results (161-170 of 495) with videos related to

Pageof 50
Sort By:
Nuclear Medicine Communications|March 5, 2008
Striatal dopamine transporter abnormalities in patients with essential tremorIoannis U Isaias, Margherita Canesi, Riccardo Benti, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 14, 2013
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's diseaseRoberta Biundo, Luca Weis, Manuela Pilleri, et al.
Expert Opinion on Pharmacotherapy|July 26, 2023
The pharmacological management of the behavioral aspects of Parkinson's disease: an updateMarta Campagnolo, Aron Emmi, Roberta Biundo, et al.
International Review of Neurobiology|October 8, 2022
Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonismValentina Leta, Iro Boura, Daniel J van Wamelen, et al.
Journal of Neurology|August 19, 2020
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson's diseaseMarina Picillo, Raffaele Palladino, Roberto Erro, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutationMaria Teresa Giordana, Carla D'Agostino, Giovanni Albani, et al.
Neuropsychiatric Disease and Treatment|August 30, 2008
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor featuresAngelo Antonini, Giovanni Abbruzzese, Paolo Barone, et al.
Journal of Neurology|April 12, 2006
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized studyPaolo Barone, Leonardo Scarzella, Roberto Marconi, et al.
Journal of Neurology|August 2, 2012
Cognitive and MRI correlates of orthostatic hypotension in Parkinson's diseaseManuela Pilleri, Silvia Facchini, Elisabetta Gasparoli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 20, 2021
Reply to: "Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy"Andrea Quattrone, Angelo Antonini, David E Vaillancourt, et al.
Pageof 50

Showing results (161-170 of 495) with videos related to

Sort By:
Pageof 50
Nuclear Medicine Communications|March 5, 2008
Striatal dopamine transporter abnormalities in patients with essential tremorIoannis U Isaias, Margherita Canesi, Riccardo Benti, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 14, 2013
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's diseaseRoberta Biundo, Luca Weis, Manuela Pilleri, et al.
Expert Opinion on Pharmacotherapy|July 26, 2023
The pharmacological management of the behavioral aspects of Parkinson's disease: an updateMarta Campagnolo, Aron Emmi, Roberta Biundo, et al.
International Review of Neurobiology|October 8, 2022
Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonismValentina Leta, Iro Boura, Daniel J van Wamelen, et al.
Journal of Neurology|August 19, 2020
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson's diseaseMarina Picillo, Raffaele Palladino, Roberto Erro, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutationMaria Teresa Giordana, Carla D'Agostino, Giovanni Albani, et al.
Neuropsychiatric Disease and Treatment|August 30, 2008
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor featuresAngelo Antonini, Giovanni Abbruzzese, Paolo Barone, et al.
Journal of Neurology|April 12, 2006
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized studyPaolo Barone, Leonardo Scarzella, Roberto Marconi, et al.
Journal of Neurology|August 2, 2012
Cognitive and MRI correlates of orthostatic hypotension in Parkinson's diseaseManuela Pilleri, Silvia Facchini, Elisabetta Gasparoli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 20, 2021
Reply to: "Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy"Andrea Quattrone, Angelo Antonini, David E Vaillancourt, et al.
Pageof 50